Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
8-KReport of unscheduled material events or corporate eventDec 23, 2010View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesDec 23, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 20, 2010View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Dec 13, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 13, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 7, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 1, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 24, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 24, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 24, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 23, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 22, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 19, 2010View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventNov 15, 2010View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventNov 9, 2010View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesNov 9, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 5, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 5, 2010View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Nov 5, 2010View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Nov 5, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 4, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 2, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 1, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 1, 2010View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionOct 29, 2010View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
1-25      26-50      51-75      76-100      101-123

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information